No Data
No Data
C.Q. Pharmaceutical's H1 Profit to Fall Up to 57%; Shares Down 3%
C.Q. Pharmaceutical Holding: 2024 Interim Performance Forecast
Express News | C.Q. Pharmaceutical Holding expects a year-on-year decrease of 49.38% to 57.17% in net income for the first half of the year.
C.Q. Pharmaceutical Holding (000950.SZ): Chairman Yuan Quan completed shareholding of 219,700 shares.
On June 27th, Gelunhui reported that C.Q. Pharmaceutical Holding (000950.SZ) has received a notice from Mr. Yuan Quan, the company's chairman, regarding the completion of the shareholding plan on June 27th, 2024. As of June 27th, 2024, the expiration date of the plan has been reached and the plan has been fully implemented. Mr. Yuan Quan has accumulated 219,700 shares of the company's stock, with a total amount of 992,227 yuan, accounting for 0.01% of the total share capital of the company. This shareholding plan has been fully implemented.
As of May 31st, the total number of shareholders of c.q. pharmaceutical holding (000950.SZ) was 40,349.
C.q. pharmaceutical holding (000950.SZ) stated on the investor interaction platform that as of May 31, 2024, the total number of shareholders of the company was 40,349.
Express News | Chongyao Group and Zhixiang Jintai have signed a global strategy cooperation agreement.
No Data